Stock 4596 KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Kubota Pharmaceutical Holdings Co., Ltd.

Equities

4596

JP3266500002

Delayed Japan Exchange
Other stock markets
 02:00:00 2024-06-11 am EDT 		5-day change 1st Jan Change
70 JPY -1.41% Intraday chart for Kubota Pharmaceutical Holdings Co., Ltd. 0.00% -12.50%
Mar. 22 Kubota Pharmaceutical Adjusts 2023 Financial Results Following Reevaluation MT
Mar. 21 Kubota Pharmaceutical Holdings Co., Ltd. Restates Consolidated and Non-Consolidated Financial Results for the Fiscal Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Kubota Pharmaceutical Adjusts 2023 Financial Results Following Reevaluation
MT
Kubota Pharmaceutical Holdings Co., Ltd. Restates Consolidated and Non-Consolidated Financial Results for the Fiscal Year Ended December 31, 2023
CI
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Kubota Pharmaceutical Group Launches Its Unique Kubota Glass Technology Aiming to Revolutionize Myopia Management
NE
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022
CI
Kubota Pharmaceutical Holdings Co., Ltd. announced that it expects to receive ¥3.1 million in funding from Barclays Bank PLC, Investment Arm
CI
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022
CI
Kubota Pharmaceutical Holdings Co., Ltd. Announces Database Lock for Phase 3 Clinical Trial of Emixustat in Patients with Stargardt Disease and Expected Release of Top-Line Results in August 2022
CI
Kubota Pharmaceutical Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2022
CI
Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2022
CI
Kubota Pharmaceutical Holdings Co., Ltd. Provides Consolidated Financial Guidance for the Year Ending December 31, 2021
CI
Kubota Pharmaceutical : Summary of Financial Results for the second quarter 2021
PU
Kubota Pharmaceutical : Consolidated Financial Results for the Six Months Ended June 30, 2021(under IFRS)
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4596 Stock
  4. News Kubota Pharmaceutical Holdings Co., Ltd.